NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $906,000 | -49.7% | 125,331 | -35.8% | 0.02% | -50.0% |
| Q2 2021 | $1,801,000 | -27.0% | 195,076 | -2.7% | 0.03% | -34.6% |
| Q1 2021 | $2,468,000 | -28.9% | 200,518 | -18.6% | 0.05% | -33.3% |
| Q4 2020 | $3,473,000 | -2.4% | 246,299 | -16.9% | 0.08% | -35.5% |
| Q3 2020 | $3,558,000 | -22.0% | 296,511 | +7.9% | 0.12% | -26.7% |
| Q2 2020 | $4,562,000 | – | 274,808 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|